Cheng Chang

Director, Clinical Pharmacology Pfizer

Seminars

Wednesday 19th November 2025
speakers
9:45 am
Wednesday 19th November 2025
Optimizing Pediatric Formulation Development Strategy Using MIDD: ~ A Case Study in Aligning the Regulatory Approval Path Without a Pediatric Trial
2:00 pm
  • Hear real-world insights from the strategy lead behind successful regulatory interactions using MIDD to reduce or eliminate clinical studies, particularly in pediatric programs 
  • Discover how purpose-fit modeling tools were applied to align both FDA and EMA expectations
  • Understand the challenges and successes in navigating complex regulatory landscapes, and how persistence helped secure regulatory alignment 
Cheng Chang